Monday, September 9, 2013

GSK reaches agreement to divest Lucozade and Ribena for £1.35 billion | 2013 | Press releases | Media | GlaxoSmithKline

GSK reaches agreement to divest Lucozade and Ribena for £1.35 billion | 2013 | Press releases | Media | GlaxoSmithKline

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.